Start for free
Start for free
Alexandria Real Estate Equities logo

Alexandria Real Estate Equities

North America, California, United States, Pasadena

Description

Alexandria Real Estate Equities is a real estate investment company.

Investor Profile

Alexandria Real Estate Equities has made 55 investments, with 1 in the past 12 months and 4% as lead.

Stage Focus

  • Series B (31%)
  • Series A (31%)
  • Series Unknown (15%)
  • Series C (13%)
  • Series D (5%)
  • Pre Seed (2%)
  • Grant (2%)
  • Seed (2%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
  • Medical
  • Pharmaceutical
  • Biopharma
  • Manufacturing
  • Life Science
  • Genetics
  • Health Diagnostics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Alexandria Real Estate Equities frequently co-invest with?

Amgen Ventures
Amgen Ventures
North America, California, United States, San Francisco
Co-Investments: 11
Canaan Partners
Canaan Partners
North America, California, United States, Menlo Park
Co-Investments: 6
InterWest Partners
InterWest Partners
North America, California, United States, Menlo Park
Co-Investments: 4
MPM Capital
MPM Capital
North America, Massachusetts, United States, Boston
Co-Investments: 10
Versant Ventures
Versant Ventures
North America, California, United States, Menlo Park
Co-Investments: 9
OVP Venture Partners
OVP Venture Partners
North America, Washington, United States, Seattle
Co-Investments: 7
Polaris Partners
Polaris Partners
North America, Massachusetts, United States, Boston
Co-Investments: 8
Lux Capital
Lux Capital
North America, New York, United States, New York
Co-Investments: 6
Venrock
Venrock
North America, California, United States, Palo Alto
Co-Investments: 6
ARCH Venture Partners
ARCH Venture Partners
North America, Illinois, United States, Chicago
Co-Investments: 23

Which angels does Alexandria Real Estate Equities often collaborate with?

SP
Stelios Papadopoulos
Europe, Germany
Shared Deals: 1
FM
Frank Moss
North America, United States
Shared Deals: 1
SH
Steven Holtzman
North America, New Hampshire, United States, Center Harbor
Shared Deals: 1

What are some of recent deals done by Alexandria Real Estate Equities?

Galatea Bio

Miami Lakes, Florida, United States

Galatea Bio’s mission is to drive groundbreaking discoveries in healthcare by pairing genetic diversity with cutting-edge data analytics.

Artificial Intelligence (AI)Big DataBiopharmaBiotechnologyHealth CareLife ScienceMachine LearningMedicalPharmaceutical
Series UnknownMar 27, 2025
Amount Raised: $8,000,000
TFC Therapeutics

Nyack, New York, United States

TFC Therapeutics is a biotechnology company developing novel biologics to target and eliminate key drivers of cancer.

BiopharmaBiotechnologyMedical
Pre SeedAug 17, 2023
Stablix

New York, New York, United States

Stablix Therapeutics is a biotechnology company pioneering the field of Targeted Protein Stabilization (TPS).

BiotechnologyHealth CareMedical
Series AJun 3, 2021
Amount Raised: $63,000,000
C2i Genomics

New York, New York, United States

C2i Genomics provides cloud-based cancer diagnostic services to pharmaceutical and diagnostic organizations.

GeneticsHealth CareHealth DiagnosticsTherapeutics
Series BApr 15, 2021
Amount Raised: $100,000,000
TerMir

Raleigh, North Carolina, United States

TerMir is an innovative AgTech company that offers pioneering solutions to address key, unresolved agronomic and environmental challenges.

AgricultureAgTechInformation Technology
GrantJul 2, 2020
Amount Raised: $100,000
Cradle Genomics

San Diego, California, United States

Cradle Genomics is a creator of a novel prenatal testing methodology

Biotechnology
Series AJul 16, 2019
Amount Raised: $17,100,000
Strand Therapeutics

Cambridge, Massachusetts, United States

Strand Therapeutics is a biopharmaceutical company applying synthetic biology to RNA therapeutics to develop single dose mRNA treatments.

BiotechnologyLife SciencePharmaceuticalTherapeutics
SeedJun 4, 2019
Amount Raised: $6,000,000
Halio

Hayward, California, United States

Halio is developing adaptive, dynamic glass for the commercial, residential, and automotive markets.

Advanced MaterialsComputerConsumer ElectronicsElectronicsIndustrialManufacturingReal EstateSmart BuildingSmart Cities
Series DJan 30, 2019
Amount Raised: $100,000,000
KSQ Therapeutics

Cambridge, Massachusetts, United States

KSQ Therapeutics is using CRISPR technology within a powerful drug discovery engine to enable high-confidence drug development.

BiopharmaBiotechnologyPharmaceuticalTherapeutics
Series CSep 28, 2018
Amount Raised: $80,000,000
KSQ Therapeutics

Cambridge, Massachusetts, United States

KSQ Therapeutics is using CRISPR technology within a powerful drug discovery engine to enable high-confidence drug development.

BiopharmaBiotechnologyPharmaceuticalTherapeutics
Series BOct 2, 2017
Amount Raised: $76,000,000
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator